US 8765933
Asynthesis of β-nucleosides
granted A61PA61P35/00
Quick answer
US patent 8765933 (Asynthesis of β-nucleosides) held by PHARMAESSENTIA CORPORATION expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PHARMAESSENTIA CORPORATION
- Grant date
- Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61P, A61P35/00